Tempus AI: In Vogue, But Better To Wait For Some Retracement

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility. ... Tempus AI: In Vogue, But Better To Wait For Some …

CouponFollow Extension

82%
OFF

Tempus AI: In Vogue, But Better To Wait For Some Retracement

3 weeks from now

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility. ... Tempus AI: In Vogue, But Better To Wait For Some …

seekingalpha.com

45%
OFF

What's Happening With Tempus AI (TEM) Stock? - Forbes

3 weeks from now

Jan 27, 2025 · Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM …

forbes.com

41%
OFF

Tempus AI Stock Before Q4 Earnings: To Buy Or Not To Buy?

3 weeks from now

Tempus AI began trading publicly on June 14, 2024. Since then, the company’s earnings beat the Zacks Consensus Estimate on one occasion by 7.41% and missed on the other by 6.78%.

yahoo.com

93%
OFF

Tempus AI: A Potential Double-Bagger After Recent Pullback

3 weeks from now

Dec 20, 2024 · In mid-August, around two months after Tempus AI’s (NASDAQ: TEM) initial public offering (IPO), the stock was up a marvelous 93%. However, shares have experienced …

nasdaq.com

15%
OFF

Google-backed Tempus AI Pops By As Much As 15% In Nasdaq …

3 weeks from now

Jun 14, 2024 · Tempus AI is applying some of the most heavily-funded technology concepts — artificial intelligence and data analysis — to building a better, more informed medical …

israelnewsonline.org

$700
OFF

Tempus AI: Don't Be Blindly Optimistic On Anything AI

3 weeks from now

Jan 28, 2025 · Note that Tempus AI is expected to achieve just under $700M in total sales for 2024, and management indicated an adjusted revenue of $1.23B (including Ambry) for 2025.

seekingalpha.com

FAQs about Tempus AI: In Vogue, But Better To Wait For Some Retracement Coupon?

Is Tempus AI a good stock to buy?

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility. A couple of days back, TEM closed the acquisition of Ambry Genetics, which we view as largely positive. TEM's preliminary Q4 and FY earnings release last month didn't have too many surprises. ...

Will Tempus be able to achieve a positive EBITDA by fy26?

However, after Tempus integrates Ambry, it will immediately pivot to positive EBITDA (on an annualized basis), and the consensus now believes that even positive net profit could be attained one year earlier (by FY26). ...

Is ambry better than Tempus?

Ambry also helps fill some gaps for Tempus. For instance, it opens doors to deploy even more genetic testing in avenues such as pediatrics, cardiology, immunology, etc. which TEM doesn’t have exposure to. Secondly, while TEM is more oriented towards the east coast of the US, Ambry offers useful exposure to the west coast. ...

Is TEM euphoria worth getting behind?

Nonetheless, since it’s been over 3 months since we last reviewed TEM (during which it also managed to close its first acquisition since going public), we felt it was appropriate to once again gauge the temperature here and see if the recent euphoria is worth getting behind. ...

Should investors wait for a pullback in TEM?

In light of all these developments, we feel investors who are looking to own TEM would be better served waiting for a pullback in the price. This article was written by Investment research, primarily oriented towards uncelebrated/under-covered stocks and ETFs, across North America, Europe and Asia. ...

Is tem a good reversion candidate?

Compared to its peers, TEM looked relatively oversold earlier this year and may have served as an ideal mean-reversion candidate. That trade no longer holds as the current RS is 23% higher than the mean. In light of all these developments, we feel investors who are looking to own TEM would be better served waiting for a pullback in the price. ...